Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Computer-Based Training for Mild Alzheimer's Disease

This study has been completed.
University of California, San Francisco
Information provided by:
Posit Science Corporation Identifier:
First received: April 27, 2006
Last updated: May 13, 2013
Last verified: May 2013
The primary objective of this study is to evaluate the effects of computer-based training program ("HiFi-AD") on the memory and cognitive abilities of individuals diagnosed with mild Alzheimer's Disease (AD).

Condition Intervention Phase
Alzheimer's Disease
Procedure: Computer-based Cognitive Training
Phase 1

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Computer-Based Training for Mild Cognitive Impairment and Mild Alzheimer's Disease

Resource links provided by NLM:

Further study details as provided by Posit Science Corporation:

Primary Outcome Measures:
  • The primary objective of this trial will be to assess the feasibility of using computer-based
  • cognitive training in an a population with early Alzheimer's Disease.

Secondary Outcome Measures:
  • A standardized set of neuropsychological assessments will be conducted pre- and post-
  • compuer-based training.

Estimated Enrollment: 6
Study Start Date: September 2004
Estimated Study Completion Date: October 2006
Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)
Detailed Description:
The purpose of this study is to determine the extent to which computer-based cognitive remediation improves cognitive functions using standardized neuropsychological assessments relevant to AD; 2) the acceptability and feasibility of using computer-based cognitive remediation in an AD population.

Ages Eligible for Study:   60 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Fluent in English.
  • Mini-Mental Status Examination (MMSE) score of 22 or higher.
  • Adequate visual capacity.
  • Adequate hearing capacity.
  • Has a caregiver with some computer experience.
  • Willing and able to commit to the time requirement of the entire study.

Exclusion Criteria:

  • Clinically significant cerebrovascular disease.
  • Participant is planning to begin acetylcholinesterase inhibitor (AChEI) therapy.
  • Participants with severe tremor.
  • Axis 1 or 2 psychiatric disorders.
  • History of substance abuse.
  • History of head trauma.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00319891

United States, California
University of California, San Francisco
San Francisco, California, United States, 94143
Sponsors and Collaborators
Posit Science Corporation
University of California, San Francisco
Principal Investigator: Joel Kramer, PsyD University of California, San Francisco
Principal Investigator: Kristine Yaffe, MD University of California, San Francisco
  More Information Identifier: NCT00319891     History of Changes
Other Study ID Numbers: OUT-109-2005
Study First Received: April 27, 2006
Last Updated: May 13, 2013

Keywords provided by Posit Science Corporation:
Mild Cognitive Impairment
Cognitive remediation
computer-based training

Additional relevant MeSH terms:
Alzheimer Disease
Mild Cognitive Impairment
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurodegenerative Diseases
Neurocognitive Disorders
Mental Disorders
Cognition Disorders processed this record on May 25, 2017